_:ne64be4a62abd4e30933ed4dbcd968936xb0
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<https://www.biospace.com/connect-biopharma-reports-cbp-201-achieved-all-primary-and-key-secondary-endpoints-in-pivotal-atopic-dermatitis-ad-trial-in-china>